You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CB-659

Showing 1 - 25 of 283
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Evanston, Illinois
  • +6 more
Dec 12, 2022

Childbirth-related Post-traumatic Stress Disorder in

Recruiting
  • Post Traumatic Stress Disorder
    • Lausanne, Vaud, Switzerland
      Lausanne University Hospital
    May 9, 2023

    Primary Hypertension Trial in Chongqing (External Ultrasonic Micro-bubble)

    Not yet recruiting
    • Primary Hypertension
    • External Ultrasonic Micro-bubble
    • Chongqing, Chongqing, China
      The Second Affilated Hospital of Chongqing Medical Universty
    Oct 30, 2023

    Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • CB-011
    • New York, New York
    • +3 more
    Feb 15, 2023

    Insomnia Trial in Ann Arbor (Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM), Sleep Hygiene Education (SHE-TM))

    Not yet recruiting
    • Insomnia
    • Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
    • Sleep Hygiene Education (SHE-TM)
    • Ann Arbor, Michigan
      University of Michigan
    Apr 3, 2023

    Postoperative Pain, Children, Only Trial in Istanbul (Regional anesthesia intervention)

    Completed
    • Postoperative Pain
    • Children, Only
    • Regional anesthesia intervention
    • Istanbul, Turkey
      Prof. Dr. Cemil Tascioglu City Hospital
    Jan 9, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Caudal Block and Other Methods of Postoperative Pain Relief in

    Completed
    • Analgesia
    • +2 more
    • caudal block
    • +2 more
    • Manama, Bahrain
      Salmanyia Medical Complex
    Oct 10, 2023

    PTSD (Childbirth-Related) Trial in Boston (Expressive Writing about Childbirth, Neutral Writing)

    Not yet recruiting
    • PTSD (Childbirth-Related)
    • Expressive Writing about Childbirth
    • Neutral Writing
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 27, 2023

    Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

    Recruiting
    • Leptomeningeal Neoplasm
    • +6 more
    • Duarte, California
    • +6 more
    Dec 29, 2022

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    PTSD, Intrusive Traumatic Memories Trial in Lausanne (A single-session behavioral intervention composed of a brief evocation of

    Recruiting
    • Posttraumatic Stress Disorder
    • Intrusive Traumatic Memories
    • A single-session behavioral intervention composed of a brief evocation of the childbirth memory followed by a Tetris gameplay
    • Lausanne, Vaud, Switzerland
      Antje Horsch
    Jul 15, 2022

    Stroke, Ischemic, Quadrantanopia, Hemianopsia, Homonymous Trial in Rochester (Virtual Reality Driving Task)

    Not yet recruiting
    • Stroke, Ischemic
    • +10 more
    • Virtual Reality Driving Task
    • Rochester, New York
      University of Rochester
    Sep 22, 2023

    Dental Caries Trial in Araçatuba (Applications of self-etching adhesives and dental restorations)

    Completed
    • Dental Caries
    • Applications of self-etching adhesives and dental restorations
    • Araçatuba, Sao Paulo, Brazil
      Cristiane Duque
    Jan 4, 2023

    Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2021

    Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)

    Completed
    Has Results
    • Triple Negative Breast Cancer
    • TNBC - Triple-Negative Breast Cancer
    • Birmingham, Alabama
    • +24 more
    Sep 19, 2022

    AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

    Terminated
    • AML
    • AML, Adult
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Cancer Center
    Mar 15, 2022

    Clostridium Difficile Infection Trial (CB-183,315, Vancomycin, Placebo)

    Completed
    Has Results
    • Clostridium Difficile Infection
    • (no location specified)
    Aug 19, 2022

    Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB

    Withdrawn
    • Sickle Cell Disease
    • +2 more
    • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
    • Palo Alto, California
    • +1 more
    Jun 29, 2022

    System for the Anticipation of Challenging Behaviors

    Completed
    • Autism Spectrum Disorder
    • Smart, non-invasive shirt - Physiological parameters
    • +2 more
    • Ariel, Israel
      Ariel University
    Dec 29, 2022

    Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

    Recruiting
    • Dry Age-related Macular Degeneration
    • Intravitreal injection of CB-PRP
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jan 23, 2023

    Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Steroid Refractory Graft Versus Host Disease
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived

    Not yet recruiting
    • Recurrent Gliosarcoma
    • +2 more
    • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
    • Resection
    • Houston, Texas
      M D Anderson Cancer Center
    May 24, 2022

    Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

    Terminated
    Has Results
    • Lymphoma, Non-Hodgkin
    • Tucson, Arizona
    • +12 more
    Dec 7, 2021

    Ovarian Cancer, Resistant BRCA Wild-Type Ovarian Cancer Trial in Birmingham (Cohort 1: Dose Escalation, Cohort 2: Dose

    Terminated
    • Ovarian Cancer
    • Resistant BRCA Wild-Type Ovarian Cancer
    • Cohort 1: Dose Escalation
    • Cohort 2: Dose Escalation
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Apr 29, 2022